These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 25916577)

  • 21. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.
    Park MJ; Park IC; Hur JH; Kim MS; Lee HC; Woo SH; Lee KH; Rhee CH; Hong SI; Lee SH
    J Neurosurg; 2002 Jul; 97(1):112-8. PubMed ID: 12134900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix metalloproteinases and epidermal wound repair.
    Martins VL; Caley M; O'Toole EA
    Cell Tissue Res; 2013 Feb; 351(2):255-68. PubMed ID: 22526628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models?
    Janssens S; Lijnen HR
    Cardiovasc Res; 2006 Feb; 69(3):585-94. PubMed ID: 16426591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interplay of angiotensin II and angiotensin(1-7) in the regulation of matrix metalloproteinases of human cardiocytes.
    Pan CH; Wen CH; Lin CS
    Exp Physiol; 2008 May; 93(5):599-612. PubMed ID: 18296491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MMPs: a novel drug target for schizophrenia.
    Chopra K; Baveja A; Kuhad A
    Expert Opin Ther Targets; 2015 Jan; 19(1):77-85. PubMed ID: 25214056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of P38 MAPK on MMP Activity in Photothrombotic Stroke Mice as Measured using an Ultrafast MMP Activatable Probe.
    Chang D; Wang YC; Bai YY; Lu CQ; Xu TT; Zhu L; Ju S
    Sci Rep; 2015 Nov; 5():16951. PubMed ID: 26581247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple roles for MMPs and TIMPs in cerebral ischemia.
    Cunningham LA; Wetzel M; Rosenberg GA
    Glia; 2005 Jun; 50(4):329-339. PubMed ID: 15846802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Matrix metalloproteinases and diseases of the central nervous system with a special emphasis on ischemic brain.
    Gasche Y; Soccal PM; Kanemitsu M; Copin JC
    Front Biosci; 2006 May; 11():1289-301. PubMed ID: 16368516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the expression of nine secreted matrix metalloproteinases and their endogenous inhibitors in the brain of mice subjected to ischaemic stroke.
    Lenglet S; Montecucco F; Mach F; Schaller K; Gasche Y; Copin JC
    Thromb Haemost; 2014 Aug; 112(2):363-78. PubMed ID: 24671655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulated expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in BALB/c mouse brain challenged with Japanese encephalitis virus.
    Shukla V; Kumar Shakya A; Dhole TN; Misra UK
    Neuroimmunomodulation; 2012; 19(4):241-54. PubMed ID: 22441541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation and silencing of matrix metalloproteinases.
    Fu X; Parks WC; Heinecke JW
    Semin Cell Dev Biol; 2008 Feb; 19(1):2-13. PubMed ID: 17689277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastric cancer - The role of matrix metalloproteinases in tumor progression.
    Lukaszewicz-Zając M; Mroczko B; Szmitkowski M
    Clin Chim Acta; 2011 Sep; 412(19-20):1725-30. PubMed ID: 21693112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations.
    Hashimoto T; Wen G; Lawton MT; Boudreau NJ; Bollen AW; Yang GY; Barbaro NM; Higashida RT; Dowd CF; Halbach VV; Young WL;
    Stroke; 2003 Apr; 34(4):925-31. PubMed ID: 12649522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracellular matrix degradation and the role of hepatic stellate cells.
    Benyon RC; Arthur MJ
    Semin Liver Dis; 2001 Aug; 21(3):373-84. PubMed ID: 11586466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction in levels of matrix metalloproteinases and increased expression of tissue inhibitor of metalloproteinase-2 in response to mild hypothermia therapy in experimental stroke.
    Lee JE; Yoon YJ; Moseley ME; Yenari MA
    J Neurosurg; 2005 Aug; 103(2):289-97. PubMed ID: 16175859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: insights from a computational model.
    Karagiannis ED; Popel AS
    J Theor Biol; 2006 Jan; 238(1):124-45. PubMed ID: 16005020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New implications of the proteolytic balance between matrix metalloproteinases and their tissue inhibitors in migraine with and without aura.
    Mannello F
    Clin Chim Acta; 2009 Nov; 409(1-2):1-3. PubMed ID: 19632213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Matrix metalloproteinases and cancer.
    Cox G; O'Byrne KJ
    Anticancer Res; 2001; 21(6B):4207-19. PubMed ID: 11908674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The role of matrixmetalloproteinases in the tumor growth and metastasis].
    Velinov N; Poptodorov G; Gabrovski N; Gabrovski S
    Khirurgiia (Sofiia); 2010; (1):44-9. PubMed ID: 21972705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of ovarian extracellular matrix remodelling by metalloproteinases and their tissue inhibitors: effects on follicular development, ovulation and luteal function.
    Smith MF; McIntush EW; Ricke WA; Kojima FN; Smith GW
    J Reprod Fertil Suppl; 1999; 54():367-81. PubMed ID: 10692869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.